Guard Therapeutics International AB (GUARD) — Cash Flow-to-Debt Ratio

Latest as of September 2025: -5.95x

Guard Therapeutics International AB (GUARD) has a Cash Flow-to-Debt Ratio of -5.95x as of September 2025, meaning its operating cash flow of Skr-90.70 Million could theoretically repay -6% of its total liabilities (Skr15.24 Million) in one year. See Guard Therapeutics International AB free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

-5.95x
Operating CF / Total Liabilities

Operating Cash Flow

Skr-90.70 Million
SEK

Total Liabilities

Skr15.24 Million
SEK

Data as of

Sep 2025
Most recent filing

Guard Therapeutics International AB Cash Flow-to-Debt Ratio (2012–2024)

Historical debt coverage capacity for Guard Therapeutics International AB across 13 annual periods. For the full cash flow conversion analysis, see GUARD cash flow metrics.

Annual Cash Flow-to-Debt Ratio for Guard Therapeutics International AB (2012–2024)

Year-by-year debt coverage analysis for Guard Therapeutics International AB.

Year CF-to-Debt Ratio Operating CF (SEK) Total Liabilities YoY Change
2024 -5.33x Skr-94.75 Million Skr17.77 Million ▲ +15.0%
2023 -6.27x Skr-116.05 Million Skr18.49 Million ▼ -55.1%
2022 -4.05x Skr-102.14 Million Skr25.24 Million ▲ +23.6%
2021 -5.29x Skr-77.59 Million Skr14.66 Million ▼ -60.8%
2020 -3.29x Skr-37.96 Million Skr11.54 Million ▲ +39.4%
2019 -5.43x Skr-60.21 Million Skr11.09 Million ▼ -180.6%
2018 -1.93x Skr-58.46 Million Skr30.21 Million ▲ +65.8%
2017 -5.65x Skr-66.01 Million Skr11.68 Million ▼ -45.9%
2016 -3.87x Skr-46.98 Million Skr12.13 Million ▼ -17.9%
2015 -3.28x Skr-29.56 Million Skr9.00 Million ▼ -173.2%
2014 -1.20x Skr-6.87 Million Skr5.71 Million ▼ -825.1%
2013 -0.13x Skr-2.83 Million Skr21.75 Million ▼ -54.7%
2012 -0.08x Skr-1.45 Million Skr17.25 Million —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.